AJR:197,August 2011
Amir Kashefi, Jonathan Kuo David K. Shelton
OBJECTIVE. In this article, we consider a multitude of the latest techniques used for evaluating benign and malignant pulmonary diseases. Our review will include mostly clinically pertinent studies, but we have also included breakthrough basic science research that has potentially significant clinical implications.
CONCLUSION. Molecular imaging enables noninvasive visualization and measurement of the dynamic molecular processes within living organisms. Early recognition of mo¬lecular and cellular malfunctions can help optimize diagnostic and therapeutic strategies.